NEW YORK, April 23, 2018 -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Akorn, Inc. (NASDAQ:AKRX) who purchased shares between March 1, 2017 and February 26, 2018. The action, which was filed in the United States District Court for the District of Illinois, alleges that the Company violated federal securities laws.
In particular, the complaint alleges that throughout the Class Period, defendants made materially false and/or misleading statements and/or failed to disclose that (1) the Company’s failure to comply with FDA data integrity requirements would jeopardize Fresenius’ acquisition of the Company; (2) the Company lacked effective internal controls over financial reporting; and (3) as a result, the Company’s financial statements were materially false and misleading at all relevant times.
Shareholders have until May 7, 2018 to petition the court for lead plaintiff status. Your ability to share in any recovery does not require that you serve as lead plaintiff. You may choose to be an absent class member.
If you suffered a loss during the class period and wish to obtain additional information, please contact Joseph Klein, Esq. by telephone at 212-616-4899 or visit http://www.kleinstocklaw.com/pslra-c/akorn-inc?wire=3.
Joseph Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Joseph Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com


SK Hynix Shares Drop After Strong Nasdaq Debut Despite $26 Billion ADR Listing
Nvidia Invests $500M in Firmus Technologies Ahead of Planned ASX IPO
Muji Owner Ryohin Keikaku Stock Soars After Raising Full-Year Earnings Forecast
SK Hynix Soars 13% in Nasdaq Debut After Record $26.5 Billion IPO
Levi Strauss Raises 2026 Outlook After Q2 Earnings Beat, Shares Drop Despite Strong Results
Morgan Stanley Says China’s Reusable Rocket Progress Poses Long-Term Challenge to SpaceX
Mastercard Explores Sale of Majority Stake in UK Payments Firm Vocalink: Report
Apple Sues OpenAI, Former Employees Over Alleged Trade Secret Theft
Bernstein Names IAG, Ryanair as Top European Airline Stocks Ahead of Earnings
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI
Nippon Paint Reportedly Offers Up to €7.5 Billion for Akzo Nobel Decorative Paints Business
Sino Biopharm Stock Rises After AstraZeneca Licensing Deal, GSK Partnership Expansion
Samsung to Launch First Yongin Chip Plant by 2029 as South Korea Speeds Up Semiconductor Hub
OpenAI Executive Fidji Simo to Step Down Amid Health Challenges Ahead of IPO
Zhipu AI Raises HK$31.37 Billion in Discounted Share Sale to Accelerate AI Growth
Kitron Q2 Revenue Beats Estimates as Defense Demand Lifts Growth 



